成年患有短肠综合征的患者接受了特杜格卢提德治疗:描述性队列研究
Dane Christina Daoud1, Katherine J P Schwenger2, Hyejung Jung3
1Division of Gastroenterology, Centre Hospitalier de l'Université de Montréal (CHUM), Department of Medicine, University of Montreal, Montreal, Quebec, Canada.
JPEN. Journal of parenteral and enteral nutrition
|July 7, 2023
概括
在患有短肠综合征 (SBS) 的成年人中,泰杜格卢提德显著降低了亲肠支 (PS). 诸如PS持续时间较长和无麻醉剂等因素有助于PS减少和断奶,促进整体自主性.
科学领域:
- 胃肠病学 胃肠病学
- 临床药理学 临床药理学
背景情况:
- 泰杜格卢提德是一种GLP-2类似物,已被批准用于慢性肠衰竭短肠综合征 (SBS-IF).
- 临床试验表明,特杜格胺降低了对肠道支 (PS) 的需求.
研究的目的:
- 为了评估18个月的泰杜格卢提德治疗对成人SBS-IF患者PS体积减小和断奶的影响.
- 确定与显著的PS体积减少 (≥20%) 和PS断奶相关的因素.
- 评估两年的临床结果.
主要方法:
- 在国家注册中对成人SBS-IF患者进行前性描述性队列研究.
- 每6个月收集的数据:人口统计,临床,生化,PS疗法和住院情况.
- 2年来PS体积减少,断奶和相关因素的分析.
主要成果:
- 2年后,74%的人实现了≥20%的PS体积减少,26%的人实现了PS独立性.
- 减少PS体积与PS持续时间更长,基底能量摄入量更低,没有麻醉剂有关.
- 断奶与输液日数较少,PS体积较低,PS持续时间较长和基线药物较少有关.
- 在患有≥20%PS体积减小的患者中观察到更少的住院和住院日数.
结论:
- 泰杜格卢提德有效降低PS体积,并促进成人SBS-IF的断奶.
- 没有麻醉剂和更长的PS持续时间是PS减少和断奶的关键因素.
- 较低的基线PS体积和较少的输液日有利于肠道自主.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
357
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
357
Inflammatory Bowel Disease V: Surgical Management
171
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
171
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
156
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
156
Chronic Bowel Disorders: Introduction
489
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
489
Inflammatory Bowel Disease II: Crohn's Disease
299
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
299
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
195
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
195


